Alnylam Pharmaceuticals
ALNY
#559
Rank
โ‚ฌ36.93 B
Marketcap
279,58ย โ‚ฌ
Share price
-0.22%
Change (1 day)
5.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company